ArticleUpdates in surgery2025

Incidence and risk factors for early thyroxin supplementation therapy after hemithyroidectomy for benign conditions in Europe. A Eurocrine® registry-based study.

Jesús M Villar-Del-Moral et al.PubMed ↗Publisher ↗

No numbers read from the abstract.